Literature DB >> 3942429

The atherosclerotic ascending aorta and transverse arch: a new technique to prevent cerebral injury during bypass: experience with 13 patients.

A T Culliford, S B Colvin, K Rohrer, F G Baumann, F C Spencer.   

Abstract

Calcification of the ascending aorta and transverse arch significantly increases morbidity and may compromise the completeness of cardiac surgical procedures. Several stratagems have been suggested to reduce the risk, but for some patients this finding is still associated with a devastating outcome, irrespective of the technique employed. Thirteen patients (7 men and 6 women with a mean age of 66 years) with extensive calcification in the ascending aorta and transverse arch underwent cardiopulmonary bypass (CPB). The presence of calcification was known prior to CPB in 12 patients and noted after cross-clamping of the aorta in 1 patient. Special techniques for cannulation of the ascending aorta or arch were undertaken in 12 patients; 1 patient required groin cannulation. In 12 patients CPB with gradual core cooling to 18 degrees C was done, during which time no manipulation of the aorta was allowed. Circulatory arrest was then initiated for 3.5 to 12 minutes. The aorta was opened widely during this time to remove ulcerated plaques and friable debris, and to locate a safe place for aortic occlusion. All patients recovered without neurological complications. In 1 patient, in whom occipital lobe infarcts developed, calcification was discovered after the aorta had been cross-clamped and necessitated subsequent endarterectomy of the ascending aorta and transverse arch.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3942429     DOI: 10.1016/s0003-4975(10)64492-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  Coronary artery bypass grafting for patients with an atherosclerotic ascending aorta.

Authors:  H Ogino; Y Ueda; T Tahata; T Sugita; J Nishizawa; K Matsuyama; S Yoshimura; T Yoshioka; Y Tokuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-04

2.  Coronary revascularization in a calcified ascending aorta: using the right gastroepiploic artery.

Authors:  W Ting; P M Scholz; A J Spotnitz
Journal:  Tex Heart Inst J       Date:  1992

Review 3.  Bad aorta.

Authors:  Kazuyoshi Tajima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-03-18

4.  Assessment of perfusion toward the aortic valve using the new dispersion aortic cannula during coronary artery bypass surgery.

Authors:  R K Grooters; K C Thieman; R F Schneider; M G Nelson
Journal:  Tex Heart Inst J       Date:  2000

5.  Right Axillary Artery Cannulation in Aortic Valve Replacement.

Authors:  Mitsuharu Hosono; Toshihiko Shibata; Takashi Murakami; Masanori Sakaguchi; Yasuo Suehiro; Shigefumi Suehiro
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-01-15       Impact factor: 1.520

6.  Strategy for reduction of stroke incidence in coronary bypass patients with cerebral lesions. Early results and mid-term morbidity using pulsatile perfusion.

Authors:  Y Takahara; Y Sudo; H Nakano; T Sato; H Ishikawa; N Nakajima
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-09

7.  Endarterectomy and external prosthetic grafting of the ascending and transverse aorta under hypothermic circulatory arrest.

Authors:  A S Olearchyk
Journal:  Tex Heart Inst J       Date:  1989

Review 8.  Shaggy and calcified aorta: surgical implications.

Authors:  Ikuo Fukuda; Kazuyuki Daitoku; Masahito Minakawa; Wakako Fukuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-02-13

9.  A no-touch technique for calcified ascending aorta during coronary artery surgery.

Authors:  B Akpinar; M Güden; I Sanisoğlu; C Konuralp; O Yilmaz; B Sönmez
Journal:  Tex Heart Inst J       Date:  1998

10.  Extraanatomical coronary artery bypass grafting in patients with severely atherosclerotic (Porcelain) aorta.

Authors:  Gokce Sirin; Kamil Sarkislali; Murat Konakci; Ergun Demirsoy
Journal:  J Cardiothorac Surg       Date:  2013-04-15       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.